Event
DiCE Proud to Be Part of #UEGWeek2024
Collaboration and partnerships are fundamental to our work, so it was a pleasure to participate in UEG Week again this year, held in Vienna. It pro...
The POLAR Promise: Groundbreaking Survival Gains for Targeted Pancreatic Cancer Patients in Phase II Trial
Phase II trial of Pembrolizumab Immunotherapy and Olaparib (POLAR) trial new data presented at the European Society for Medical Oncology (ESMO) 202...
DiCE at ESMO 2024
Earlier this month, part of the DiCE Medical and Scientific Team attended the ESMO (European Society for Medical Oncology) Congress 2024 in Barcelo...
Early-Age Onset Digestive Cancers – a Global Review of this Worrisome Trend
Early-age onset digestive cancers are worrisomely on the rise. To bring awareness to this topic, DiCE is partnering with its Member Organisation,...
Uniting for Liver Health: DiCE Advances Dialogue at the 59th EASL Congress in Milan
Digestive Cancers Europe was an active participant in the 59th edition of the European Association for the Study of the Liver Congress in Milan fro...
Putting a Spotlight on Digestive Cancers in the Polish Parliament
On May 21, DiCE, together with our Polish member organisation EuropaColon Poland Foundation, had the pleasure of voicing the concerns of digestive ...
Economist Impact: World Cancer Series Europe
On 20 September, the Belgian delegation of the DiCE Team attended the Economist Impact’s World Cancer Series: Europe in Brussels, proudly sup...
DiCE at the WECAN Retreat 2023
DiCE attended the Workgroup of European Cancer Patient Advocacy Networks (WECAN) retreat on the 20 and 21 April in Frankfurt (Germany). WECAN is a ...
Calling on EU Institutions to Address the Growing Burden of Digestive Cancers
Our CEO, Zorana Maravic, joined United European Gastroenterology (UEG) on 26 April at the European Parliament in Brussels to call for more action t...
Highlights from the EASL Liver Cancer Summit
The European Association for the Study of the Liver (EASL) held the Liver Cancer Summit, its annual conference focused on liver cancer in Estoril, ...
